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A B S T R A C T
Background: Percutaneous mitral valvuloplasty is the treatment of choice for rheumatic mitral stenosis 
with favorable anatomy, for its ability to prevent complications inherent to a surgical procedure, while 
maintaining effectiveness. It is necessary to promote comparisons between the results obtained by the 
procedure performed at referral centers with high patient inflow and at institutions with lower volume 
and fewer patients, which represents the main objective of this study.
Methods: Thirty-one consecutive patients undergoing percutaneous mitral valvuloplasty were analyzed 
from September 2006 to January 2015. Immediate procedural success and late event-free survival rates 
were evaluated, defined as cardiovascular death or need for a new mitral valve intervention.
Results: The mean age was 40.9 ± 14.2 years, with a predominance of females (96.8%). The mean Wilkins 
and Block score was 8.1 ± 1.2. All procedures were performed using the Inoue technique, with an 
immediate success rate of 90.3%. At mean follow-up of 6.8 ± 2.5 years, seven events (22.6%) were observed: 
two cardiovascular deaths, four surgeries for mitral valve replacement, and one mitral commissurotomy.
Conclusions: In a hospital with intermediate procedure volume, the results of percutaneous mitral 
valvuloplasty in the treatment of rheumatic mitral stenosis with favorable anatomy were comparable to 
those achieved by high-volume centers.
© 2015 Sociedade Brasileira de Hemodinâmica e Cardiologia Intervencionista. Published by Elsevier Editora Ltda. 
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 
 
Desfechos hospitalares e tardios de pacientes submetidos à valvoplastia mitral 
percutânea em centro com volume intermediário de procedimentos estruturais
R E S U M O
Introdução: A valvoplastia mitral percutânea é o tratamento de escolha da estenose mitral reumática com 
anatomia favorável, por sua capacidade de prevenir complicações inerentes ao tratamento cirúrgico e 
com manutenção da eficácia. Faz-se necessário promover comparações entre os resultados obtidos com o 
procedimento por centros de referência e alta drenagem de pacientes e por instituições de menor volume e 
casuística, sendo este o objetivo principal deste estudo. 
Métodos: Foram analisados 31 pacientes consecutivos submetidos à valvoplastia mitral percutânea 
no período de setembro de 2006 a janeiro de 2015. Avaliaram-se o sucesso imediato do procedimento 
e a sobrevida livre de eventos tardios, definidos como morte cardiovascular ou necessidade de nova 
intervenção valvar mitral.
Resultados: A média de idade foi de 40,9 ± 14,2 anos, com predomínio do sexo feminino (96,8%). O escore 
médio de Wilkins e Block foi de 8,1 ± 1,2. A totalidade dos procedimentos foi efetivada pela técnica de Inoue, 
com taxa de sucesso imediato de 90,3%. Em acompanhamento médio de 6,8 ± 2,5 anos, foram constatados 
sete eventos (22,6%), sendo dois óbitos de etiologia cardiovascular, quatro cirurgias de troca valvar mitral 
e uma comissurotomia mitral.
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Conclusões: Em um hospital com volume intermediário de procedimentos, os resultados da valvoplastia 
mitral percutânea no tratamento da estenose mitral reumática com anatomia favorável foram comparáveis 
àqueles alcançados por centros de alto referenciamento.
© 2015 Sociedade Brasileira de Hemodinâmica e Cardiologia Intervencionista. Publicado por Elsevier Editora Ltda. 
Este é um artigo Open Access sob a licença de CC BY-NC-ND (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
The prevalence of rheumatic fever, the predominant etiology 
of mitral stenosis, has undergone a significant reduction in Wes-
tern countries, but percutaneous mitral valvuloplasty (PMV) is 
still the treatment of choice in patients with favorable valve ana-
tomy, for its ability to prevent complications inherent to the sur-
g ic a l  procedure,  whi le maint a in ing ef fec t iveness .1-3 T he 
procedure can be accomplished by different methods, such as the 
single balloon, double balloon, or metallic commissurotomy me-
thod, with the Inoue4 technique representing the most common-
ly used, as it is simpler to perform, has a shorter procedure 
duration, and has lower incidence of complications, with late 
evolution comparable to that of the others.5-7
In spite of the frequent need for reinterventions after a successful 
PMV, survival free of cardiovascular death, surgical valve replace-
ment or NYHA class III or IV are approximately 50% in a follow-up 
period of up to 20 years in high-volume centers.8,9 It is necessary, 
however, to promote comparisons between the results obtained 
with the procedure as performed by referral centers with high pa-
tient inflow and by institutions with lower volume and fewer pa-
tients, which represents the main objective of this study.
Methods
Study population
The study population consisted of a cohort of 31 consecutive pa-
tients with moderate to severe mitral stenosis of rheumatic etiology 
(mitral valve area ≤ 1.5 cm2), clinically symptomatic (functional class 
> II), with favorable valve morphology, submitted to PMV at Santa 
Casa de Marília, in Marília (SP), Brazil, from September 2006 to Janu-
ary 2015.
Procedures
Under superficial sedation and local anesthesia, right femoral 
venous access was obtained with a 7 F femoral sheath, while left 
femoral arterial access was obtained with a 5 F femoral sheath. 
Pulmonary capillary, main pulmonary artery, right ventricle, right 
atrium, left ventricle, and aorta pressures were obtained retrogra-
dely. Left ventriculography was performed in right anterior oblique 
projection at 30°, and the degree of mitral regurgitation was esta-
blished according to Sellers’ classification. In patients older than 40 
years, the assessment was complemented with coronary angiogra-
phy.
The Brockenbrough technique was used for the transseptal punc-
ture, under continuous pressure monitoring and using a pigtail ca-
theter positioned above the aortic valve as reference. After the 
transseptal puncture, a Mullins catheter was maintained in the left 
atrial cavity, and 2,500 IU of heparin were administered. After the 
mitral valve pressure gradient was recorded, the spiral guidewire 
was introduced up to the left atrium, followed by atrial septum dila-
tion using a 14 F dilator. The Inoue balloon size was determined by 
the formula given by the equation:
maximum balloon diameter (mm) = [patient's height (m) × 10] + 10
The balloon was advanced over the guidewire, with its distal extremi-
ty close to the mitral valve orifice. The balloon was then partially inflated 
with 1 to 2 mL of diluted contrast to facilitate its fluctuation through the 
valve orifice and prevent its passage through the chordae tendineae. 
With the help of a stylet, the balloon was directed in order to surpass the 
mitral valve. The distal portion of the balloon was inflated and the set 
was retracted up to its anchoring position at the ventricular face of the 
mitral valve. Then, the proximal portion of the balloon was inflated, re-
sulting in an hourglass shape, until the medial constraint disappeared at 
full inflation. The pigtail catheter was advanced into the left ventricular 
cavity for analysis of residual mitral gradient. When available, two-di-
mensional transthoracic echocardiography was performed at this point. 
If the result was considered inadequate, the balloon was introduced 
again for additional inflations with larger volume. At the end of the pro-
cedure, manometry of the right chambers and the control left ventriculo-
graphy were recorded. Echocardiography was routinely performed 24 to 
48 hours after the PMV, with the mitral valve area being assessed by pla-
nimetry.
Definitions and outcomes of interest
Procedural success was defined by the increase in mitral valve 
area ≥ 25% of the original area and final valve area ≥ 1.5 cm², in the 
absence of severe mitral regurgitation (> 2/4) and severe cardiac or 
cerebrovascular adverse events, such as death, stroke, cardiac tam-
ponade, or mitral valve surgery. The outcomes assessed in the late 
follow-up were cardiovascular death and the need for a new percu-
taneous or surgical mitral valve intervention.
Statistical analysis
All data were prospectively stored in a registry started in 2006. 
The estimate of event-free survival was determined according to the 
Kaplan-Meier method. The qualitative variables were summarized as 
absolute frequencies and percentages. Quantitative data were expres-
sed as means and standard deviations.
Results
Clinical and demographic characteristics of patients are shown in 
Table 1. The mean age was 40.9 ± 14.2 years, with a predominance of 
females (96.8%). The mean Wilkins and Block score was 8.1 ± 1.2. 
Among the procedures, one was performed in a pregnant woman 
and five in patients with previous mitral commissurotomy. After 
2007, there was stabilization in the mean volume of cases, with the 
performance of approximately four PMVs per year.
All of the procedures were carried out using the Inoue technique. 
The success rate was 90.3%, and the three unsuccessful procedures 
were attributed to transseptal puncture failure (n = 2) and cardiac 
tamponade (n = 1). Transthoracic echocardiography monitoring was 
used in 80.6% of cases. The characteristics of the echocardiographic 
procedures and information are shown in Table 2.
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Seven events (22.6%) were observed during a mean follow-up of 
6.8 ± 2.5 years: two cardiovascular deaths, four mitral valve replace-
ment surgeries, and one mitral commissurotomy. The estimate of 
event-free survival at 8 years by the Kaplan-Meier method was 
72.5% (Fig. 1). In the subgroup of patients with previous mitral com-
missurotomy (16.1%), immediate success was obtained in all cases, 
and the late follow-up showed one case of restenosis with mitral val-
ve replacement surgery.
Discussion
A pioneering modality in the non-surgical approach to acquired 
valvular disease, PMV is a complex procedure, associated with a le-
arning curve, especially due to the need for transseptal puncture. 
Late outcomes of large series of patients have been recently pu-
blished, demonstrating that it is a well-established technique that 
brings long-term benefits to patient prognosis.
Of the 1,024 patients undergoing PMV between the years 1986 
and 1995 in France, the survival free of cardiovascular death or 
new surgical or percutaneous mitral valve intervention in 20 years 
was 30.2%.9 In mean follow-up of 11.6 years of 482 patients who 
underwent the procedure in an Italian registry, the event rate was 
41.9%, mainly due to the need for mitral valve surgery (27%).10 In 
Brazil, very late outcomes involving up to 308 patients demonstra-
ted lasting results, with restenosis-free survival over 20 years in 
more than one-third of the cases.11,12 Together, these data reflect 
the experience of major referral centers in structural interventions 
with high patient inflow.
The present series, although modest, shows a high success rate, 
and low complication and event-free survival rates, comparable to 
those in large centers.13 Some aspects may justify these findings. The 
main aspect is the selection of patients favorable to the used techni-
que, such as non-advanced age, prevalence of sinus rhythm (90.3%), 
and mean echocardiographic score of 8.1 – factors that are known to 
be associated with better late outcomes.9,12,14 Speculatively, another 
strategy used on a recurring basis and that could help prevent com-
plications was the periprocedural echocardiographic monitoring in 
80.6% of cases. As the echocardiography in the intervention labora-
tory provides fast and accurate information of the mitral valve area 
and the degree of regurgitation, additional balloon inflations can be 
prevented and the subsequent establishment or worsening of valve 
regurgitation.
A subgroup of patients undergoing PMV of special interest are tho-
se with restenosis after surgical mitral commissurotomy, as percuta-
neous treatment, when feasible, prevents valve replacement and its 
consequent late implications. However, the previous commissuro-
tomy is traditionally considered a variable that predicts worse imme-
diate and late post-procedural outcomes.15 The present data were 
favorable in this population, in line with the most recent publications, 
which show immediate success in over 80% of cases and survival free 
of mitral surgery in 20 years in up to one-third of the patients.16
Table 1
Clinical and demographic characteristics of patients.
Variables n = 31
Age, years 40.9 ± 14.2
Female gender, n (%) 30 (96.8)
Body mass index, kg/m2 26.4 + 6.0
Systemic arterial hypertension, n (%) 4 (12.9)
Diabetes mellitus, n (%) 2 (6.5)
Dyslipidemia, n (%) 3 (9.7)
Smoking, n (%) 4 (12.9)
Coronary atherosclerosis, n (%) 4 (12.9)
Previous stroke, n (%) 3 (9.7)
Atrial fibrillation, n (%) 3 (9.7)
Pregnant patient, n (%) 1 (3.2)
Previous mitral commissurotomy, n (%) 5 (16.1)
Previous mitral valvuloplasty, n (%) 0 (0.0)
Wilkins and Block valvular score 8.1 ± 1.2
Heart failure, n (%)
Functional class II 10 (32.2)
Functional class III 18 (58.1)
Functional class IV 3 (9.7)
Year of the procedure, n
2006 1
2007 8
2008 4
2010 5
2011 4
2012 4
2013 0
2014 4
2015 1
Table 2
Characteristics and outcomes of percutaneous mitral valvuloplasty.
Variable n = 31
Inoue technique, n (%) 31 (100.0)
Access, n (%)
Right femoral vein 29 (93.5)
Left femoral vein 2 (6.5)
Procedure duration, minutes 71.4 ± 21.7
Time of fluoroscopy, minutes 18.1 ± 9.5
Periprocedural transthoracic echocardiography, n (%) 25 (80.6)
Procedural success, n (%) 28 (90.3)
Mitral valve area, pre-valvuloplasty cm2 0.9 ± 0.2
Mitral valve area, post-valvuloplasty, cm2 1.8 ± 0.3
Mean diastolic transvalvular gradient, pre-
valvuloplasty, mmHg
16.8 ± 4.9
Mean diastolic transvalvular gradient, post-
valvuloplasty, mmHg
3.9 ± 2.2
Mean pulmonary arterial pressure, pre-valvuloplasty, 
mmHg
37.7 ± 12.6
Mean pulmonary arterial pressure, post-valvuloplasty, 
mmHg
28.6 ± 9.2
Figure 1. Estimate of cardiovascular death or new mitral valve procedure-free sur-
vival over 8 years.
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The main limitation of the study was the small sample size and 
the reproducibility of its findings. Despite the intermediate volume 
of procedures, the interventionists involved with these procedures 
directly participated, during their training, in approximately 30 
PMV, thus meeting the learning curve. With the decrease in the 
prevalence of rheumatic mitral stenosis, acquiring proficiency in 
the stages of the procedure, such as transseptal puncture, becomes 
impaired. However, the advent of new imaging technologies and 
devices applicable in several types of structural and degenerative 
diseases, the left atrial appendage closure in patients with atrial 
fibrillation, and the therapeutic role in arrhythmias have the po-
tential to rescue the puncture technique due to the common need 
to have antegrade access to the left atrium.
Conclusions
The results obtained with the Inoue technique in percutaneous 
mitral valvuloplasty in patients with rheumatic mitral stenosis in a 
tertiary hospital with an intermediate volume of structural proce-
dures were comparable to those achieved by reference centers with 
high patient inflow.
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